Cite

HARVARD Citation

    Fauchier, L. et al. (n.d.). 59-01: SafeR is associated with a risk reduction of first-onset AF in patients with atrio-ventricular blocks: results from the ANSWER study. Europace. p. i170. [Online]. 
  
Back to record